Treating COVID-19: A pharmaceutical executive’s view
McKinsey
MAY 27, 2020
Cedric Francois, the CEO of pharmaceutical company Apellis, discusses possible approaches to treating COVID-19 patients.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
McKinsey
MAY 27, 2020
Cedric Francois, the CEO of pharmaceutical company Apellis, discusses possible approaches to treating COVID-19 patients.
Vantage Circle
MAY 10, 2021
All of which will imply how the pharmaceutical industry is likely to conduct its business in the near future. With the constant layoffs, corporate mergers and acquisitions in the pharmaceutical market, and rise in the compensation standards, many businesses have also adopted an outsourcing business model. Development in Technology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
McKinsey
SEPTEMBER 17, 2020
Our GOLD standard will help transform your pharmaceutical brand and achieve accelerated growth.
McKinsey
FEBRUARY 12, 2021
Increasingly, small biopharmaceutical companies are launching their new drugs themselves rather than relying on large pharma companies to do it for them. How can they get it right the first time?
McKinsey
MARCH 2, 2021
Santen CIO Minori Hara explains how IT is enabling the ophthalmological company to deliver a holistic sense of well-being around eye health.
McKinsey
JULY 21, 2022
Pharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better ensure patient outcomes.
McKinsey
FEBRUARY 27, 2023
Pharmaceutical companies are using recent advances in digital technologies to improve care strategies and provide hope for rare disease patients across thousands of different rare diseases.
Strategy+Business
FEBRUARY 22, 2018
And although the pharmaceutical and healthcare industries know this is the way forward, they face some significant hurdles. Precision medicine combines business opportunities with clinical health benefits.
McKinsey
AUGUST 4, 2022
By building certain functional and leadership skills, pharma companies can not only improve the odds of a successful launch but also strengthen their organizations for the future.
McKinsey
SEPTEMBER 23, 2021
Pharmaceutical supply chains have become global and complex. With more outsourcing, new modalities, and novel ways to reach patients, it’s critical to ensure that they can withstand shocks.
McKinsey
JUNE 12, 2023
The former CEO and executive chairman of the pharmaceutical company offers candid reflections on how crises tested his commitment to values—both Merck’s and his own.
McKinsey
JUNE 18, 2021
Pharmaceutical companies should reflect on their strategic stance to this promising new technology now. Quantum computing’s ability to simulate larger, more complex molecules could be game changing.
McKinsey
MARCH 21, 2022
Pharmaceutical and life sciences companies can unlock new opportunities, help underserved patients, and build a cycle of trust.
McKinsey
SEPTEMBER 20, 2022
Roche Pharmaceuticals’ approach to rare conditions highlights industry efforts to make a difference for patients, their caregivers, and healthcare professionals.
McKinsey
JANUARY 10, 2022
Pharmaceutical and medical-device companies can get the most value from “smart quality” processes enabled with new technologies by adopting a holistic approach to building culture and capabilities.
McKinsey
MARCH 8, 2023
Laboratory technology has been a steady runner in the world of pharmaceuticals, rather than a racing star—until now. A series of innovations points toward exponential gains in R&D productivity.
Correlation One
APRIL 7, 2022
of the Janssen Pharmaceutical Companies of Johnson & Johnson to learn more about data and healthcare innovation. Meet Najat Khan, Ph.D.
McKinsey
DECEMBER 10, 2021
The CFO of the pharmaceutical company talks about what it took to develop a COVID-19 vaccine.
McKinsey
JUNE 9, 2022
Emerging biotechnology companies are less satisfied than large pharmaceutical companies with their contract research organizations (CROs). How can CROs raise their game with this key segment?
McKinsey
JULY 15, 2021
Anne Nijs explains how the rare-disease group at Roche Pharmaceuticals pioneered a new model that puts the patient experience at the center of healthcare innovation and delivery.
McKinsey
JANUARY 29, 2021
Pharmaceutical and medtech companies can dramatically improve quality assurance processes by applying a ‘smart quality’ lens and cutting-edge technologies.
McKinsey
DECEMBER 15, 2020
As pharmaceutical companies reshape their commercial models to prepare for the uncertainties ahead, personalization and digital enablement will be crucial to launch success in the new environment.
McKinsey
JANUARY 11, 2023
In the wake of the COVID-19 pandemic, one of the first non-French leaders of the pharmaceutical company Sanofi explains cultural transformations, the growth of AI in decision making, and how he stays humble.
McKinsey
OCTOBER 11, 2018
There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios.
McKinsey
OCTOBER 4, 2019
Blurring the lines between pharmaceuticals and medical technology, cybermedicine has the potential to become a pillar of medical treatment and play a key role in the future of medtech innovation.
McKinsey
JULY 23, 2019
Pharmaceutical companies are increasingly turning to the concept of agility to help them transform their R&D functions.
McKinsey
DECEMBER 15, 2018
A McKinsey study points to areas pharmaceutical companies can address to combat this long-standing industry issue. When patients fail to follow prescribed medical regimens, outcomes suffer.
McKinsey
JULY 31, 2020
Christophe Weber, CEO of Takeda Pharmaceuticals, discusses challenges to globalization, principles in the face of crises, and new opportunities when companies pull together.
McKinsey
SEPTEMBER 16, 2020
Adopting a through-cycle approach to deal making in the wake of the COVID-19 pandemic can position pharmaceutical companies for greater success in the next normal.
McKinsey
JANUARY 11, 2019
A comprehensive analysis of the business, economic, and public-health impact finds the potential for local production of pharmaceuticals to be a mixed bag.
McKinsey
MAY 20, 2020
Governments, healthcare providers, and pharmaceutical companies are battling COVID-19 on different fronts. Thermo Fisher Scientific is at the nexus of all of these endeavors.
McKinsey
AUGUST 16, 2018
Data and digitization are creating a growing array of value-creation choices in industries as diverse as pharmaceuticals, mining, and energy.
McKinsey
AUGUST 13, 2019
Pharmaceutical companies can reap huge rewards from the hundreds of smaller projects they manage, not just from the occasional big one. Thinking about value, not just costs, is key.
McKinsey
MARCH 10, 2017
We spoke to ten digital leaders at global pharmaceutical companies to understand how they focus their efforts. The life-sciences industry is embracing digital to unlock innovation.
She Owns Success
APRIL 25, 2024
Positive Displacement Pumps: Applications: Used in industries that handle viscous fluids or fluids containing suspended or fragile solids, like the food and beverage industry, pharmaceuticals, and cosmetics. Types include gear pumps, screw pumps, and peristaltic pumps.
The Creative Mind
MAY 28, 2022
Conventional western medicine, often called allopathic medicine, is the system of medicine taught at most medical schools and most pharmaceutical and synthetic medicines are […]. The post Natural medicine for depression – naturopathy and supplements appeared first on The Creative Mind.
McKinsey
JULY 31, 2018
By going digital, biotech pioneers with promising biomolecular platforms are improving drug discovery and development—and changing the pharmaceutical industry.
International Coach Academy
JUNE 22, 2022
Take companies in the global pharmaceutical industry as an example. 2020), Cultural diversity drives innovation: modeling in the global pharmaceutical industry , International Journal of Innovation Science, Vol. Then, together the crew can create values based on the conversation and increase mutual understanding. Jones et al.,
McKinsey
AUGUST 3, 2018
Two senior Boehringer Ingelheim executives, Joachim Hasenmaier and Felix Gutsche, discuss the global pharmaceutical company’s deal with Sanofi to acquire its animal health business.
McKinsey
MAY 4, 2016
Here’s how pharmaceutical companies can better understand the way people make decisions about their care. Consumers have access to more healthcare information than ever.
McKinsey
DECEMBER 6, 2016
A partner of venture-capital firm Atlas Venture, Bruce Booth, explains how investment assists pharmaceutical innovation.
McKinsey
OCTOBER 27, 2017
The CEO of Eli Lilly offers perspectives on accelerating change in the industry.
McKinsey
SEPTEMBER 1, 2018
Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.
McKinsey
MAY 5, 2017
The country is rolling out a new approach to pharmaceutical distribution. What can medical-device companies expect, and how should they prepare?
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content